Point of Care Infectious Disease Testing Market Forecasts Impressive Growth at 5.6% CAGR, Reaching USD 12.0 Billion Valuation by 2035

WiseGuy Reports, Oct. 2025 (Press Release) – The Point of Care Infectious Disease Testing Market Global Outlook:

Global Point of Care Infectious Disease Testing Market Growth Analysis and Trends Report Test Type (Molecular Tests, Antigen Tests, Antibody Tests, Nucleic Acid Tests), By Product (Instruments, Reagents, Kits, Software), By End User (Hospitals, Diagnostic Laboratories, Home Care Settings, Pharmacies), By Pathogen Type (Bacterial Infectious Diseases, Viral Infectious Diseases, Parasitic Infectious Diseases, Fungal Infectious Diseases) and By Regions - Global Industry Forecast 2025 to 2035

Point of Care Infectious Disease Testing Market Overview

The Point of Care Infectious Disease Testing Market is witnessing robust growth, driven by technological advancements, increasing prevalence of infectious diseases, and a shift toward decentralized diagnostics. In 2024, the market size reached USD 6.57 billion and is projected to grow to USD 6.93 billion in 2025. By 2035, the market is expected to reach USD 12.0 billion, reflecting a CAGR of 5.6% during the forecast period from 2025 to 2035. Point of care (POC) testing enables rapid diagnosis of infectious diseases at or near the site of patient care, offering faster results, improved patient management, and enhanced healthcare efficiency.

Request To Free Sample of This Strategic Report: https://www.wiseguyreports.com/sample-request?id=735652

Market Segmentation

The Point of Care Infectious Disease Testing Market is segmented by test type, product, end user, pathogen type, and region. Test types include molecular diagnostics, immunoassays, rapid antigen tests, and serology tests. Products encompass standalone POC devices, consumables, and integrated testing systems designed to provide accurate and timely results.

End users include hospitals, clinics, diagnostic laboratories, physician offices, and home healthcare settings. Pathogen types focus on viral infections, bacterial infections, fungal infections, and parasitic infections, reflecting the diverse applications of POC diagnostics. Regional coverage spans North America, Europe, APAC, South America, and MEA, with key countries including the US, Germany, UK, China, India, Japan, Brazil, and GCC nations. North America dominates the market due to advanced healthcare infrastructure, early adoption of rapid diagnostics, and strong R&D capabilities. Emerging regions are witnessing growth driven by increasing disease prevalence, rising healthcare expenditure, and growing awareness of POC testing benefits.

Key Market Dynamics

Several factors are driving the growth of the Point of Care Infectious Disease Testing Market. Technological advancements, including automated POC devices, digital reporting, and multiplex testing systems, are improving accuracy, speed, and ease of use. Increasing prevalence of infectious diseases, including influenza, HIV, hepatitis, COVID-19, and antibiotic-resistant infections, is boosting demand for rapid diagnostic solutions.

Rising demand for rapid diagnostics enables timely treatment, reduces hospital stays, and supports infection control, particularly in high-risk environments. The shift toward decentralized testing, including home-based and community-based testing models, is enhancing accessibility and patient convenience. Additionally, growing healthcare expenditure worldwide is enabling the adoption of advanced POC testing solutions across hospitals, clinics, and remote locations.

You Can Purchase Complete Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735652

Competitive Landscape

The Point of Care Infectious Disease Testing Market is highly competitive, with companies focusing on innovation, strategic partnerships, and market expansion. Key players profiled include Hippo Technologies, Mylan N.V., Ellume, Quidel Corporation, Hologic, Thermo Fisher Scientific, Cepheid, Abbott Laboratories, GenMark Diagnostics, Zymergen, OraSure Technologies, Biomeriux, PointCare Technologies, Roche Diagnostics, Response Biomedical, BD (Becton, Dickinson and Company), and Siemens Healthineers.

These companies are investing in next-generation POC devices, rapid antigen tests, and molecular diagnostics with enhanced sensitivity and specificity. Strategic collaborations with hospitals, laboratories, and digital health platforms are accelerating adoption and integration of POC testing. Product innovations focusing on ease of use, portability, and digital connectivity are strengthening competitive positioning in this expanding market.

Market Opportunities

The Point of Care Infectious Disease Testing Market presents significant growth opportunities. Rapid technological advancements, including AI-assisted diagnostics, multiplex assays, and portable testing devices, are driving adoption in clinical and home settings. Increasing demand for home-based testing solutions is creating avenues for innovative device development and consumer engagement.

Rising prevalence of infectious diseases across emerging markets is fueling demand for accessible and cost-effective testing solutions. Integration with digital health platforms and electronic health records is improving result reporting, patient monitoring, and data analytics. Additionally, expansion into emerging regions with limited laboratory infrastructure offers substantial growth potential for POC testing providers.

Market Forecast and Outlook

The Point of Care Infectious Disease Testing Market is projected to grow steadily from 2025 to 2035, with a CAGR of 5.6%. North America is expected to maintain market leadership due to robust healthcare infrastructure, high adoption of advanced POC devices, and significant investment in R&D. Europe is anticipated to show moderate growth, driven by early adoption of rapid diagnostics, reimbursement policies, and strong regulatory support. APAC, South America, and MEA are emerging as high-growth regions, supported by rising disease prevalence, expanding healthcare infrastructure, and increasing patient awareness.

The market outlook highlights opportunities for product innovation, strategic collaborations, and digital integration. Companies focusing on portable, rapid, and multiplex POC testing systems, combined with data-driven digital health solutions, are well-positioned to capture a larger share of the Point of Care Infectious Disease Testing Market.

Reasons To Buy The Point of Care Infectious Disease Testing Market Report:

➼ In-depth analysis of the Point of Care Infectious Disease Testing Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Other Related Reports from Latest WiseGuy Reports:

Klebsiella Testing Market

Kids Wheelchair Market

Intracranial Implants Market

Lung Disease Therapeutic Drug Market

Insufflation Bulb Market

LED Color Radiology Display Market

Lyophilized Microspheres Service Market

Medical CPR Bag Market

Micro Saw Handpiece Market

Microbial Identification Panel Market

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets